BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dubchak N, Falasca GF. New and improved strategies for the treatment of gout. Int J Nephrol Renovasc Dis 2010;3:145-66. [PMID: 21694941 DOI: 10.2147/IJNRD.S6048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Li YJ, Chen LR, Yang ZL, Wang P, Jiang FF, Guo Y, Qian K, Yang M, Yin SJ, He GH. Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis. Clin Rheumatol 2022. [PMID: 36036279 DOI: 10.1007/s10067-022-06356-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Hilsabeck TAU, Liu-Bryan R, Guo T, Wilson KA, Bose N, Raftery D, Beck JN, Lang S, Jin K, Nelson CS, Oron T, Stoller M, Promislow D, Brem RB, Terkeltaub R, Kapahi P. A fly GWAS for purine metabolites identifies human FAM214 homolog medusa, which acts in a conserved manner to enhance hyperuricemia-driven pathologies by modulating purine metabolism and the inflammatory response. Geroscience 2022. [PMID: 35381951 DOI: 10.1007/s11357-022-00557-9] [Reference Citation Analysis]
3 Daoudi NE, Bouhrim M, Ouassou H, Bnouham M. Medicinal Plants as a Drug Alternative Source for the Antigout Therapy in Morocco. Scientifica (Cairo) 2020;2020:8637583. [PMID: 33299636 DOI: 10.1155/2020/8637583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Simamora A, Santoso AW, Timotius KH, Rahayu I. Antioxidant Activity, Enzyme Inhibition Potentials, and Phytochemical Profiling of Premna serratifolia L. Leaf Extracts. Int J Food Sci 2020;2020:3436940. [PMID: 33029485 DOI: 10.1155/2020/3436940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Collins MW, Saag KG, Singh JA. Is there a role for cherries in the management of gout? Ther Adv Musculoskelet Dis 2019;11:1759720X19847018. [PMID: 31205513 DOI: 10.1177/1759720X19847018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
6 Mohamed Isa SSP, Ablat A, Mohamad J. The Antioxidant and Xanthine Oxidase Inhibitory Activity of Plumeria rubra Flowers. Molecules 2018;23:E400. [PMID: 29438299 DOI: 10.3390/molecules23020400] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
7 Cai W, Wu J, Liu W, Xie Y, Liu Y, Zhang S, Xu W, Tang L, Wang J, Zhao G. Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor. Molecules 2018;23:E252. [PMID: 29382075 DOI: 10.3390/molecules23020252] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
8 Meng Q, Zhao T, Kang D, Huang B, Zhan P, Liu X. The development of an effective synthetic route of lesinurad (RDEA594). Chem Cent J 2017;11:86. [PMID: 29086884 DOI: 10.1186/s13065-017-0316-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
9 Zhao P, Chen KL, Zhang GL, Deng GR, Li J. Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition. Evid Based Complement Alternat Med 2017;2017:2103254. [PMID: 28250791 DOI: 10.1155/2017/2103254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
10 Azevedo VF, Buiar PG, Giovanella LH, Severo CR, Carvalho M. Allopurinol, benzbromarone, or a combination in treating patients with gout: analysis of a series of outpatients. Int J Rheumatol 2014;2014:263720. [PMID: 24719620 DOI: 10.1155/2014/263720] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
11 Lü JM, Yao Q, Chen C. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout. Biochem Pharmacol 2013;86:1328-37. [PMID: 23994369 DOI: 10.1016/j.bcp.2013.08.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]